Sarepta | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

THIS SITE IS INTENDED FOR HEALTHCARE PROFESSIONALS ONLY.

Sponsorship statement: This is a non-promotional meeting funded and organised by Sarepta and Roche. These presentations and discussions are for educational purposes only and solely intended to provide scientific information on certain diseases. Nothing in these presentation and discussions should be construed as seeking to promote any of Sarepta or Roche’s therapies. Nothing in these presentations should be disclosed externally without the prior agreement of Sarepta and Roche.

Practical experiences from running gene therapy trials with Adeno-Associated Virus (AAV) vectors: The Primary Investigator's perspective

XX November 2020 | 18:00 GMT/19:00 CET

Live Webinar

Participate

Pan-European Faculty

Managing gene therapy trials: Sharing best practice

Practical experiences from running gene therapy trials with Adeno-Associated Virus (AAV) vectors: The Primary Investigator's perspective

The importance of gene therapy in major therapy areas is increasing year on year, and consequently gene therapy trials are being instigated. Yet relatively few centres across Europe have experience of running clinical trials in this complex area.

This online event is a new initiative from Sarepta and Roche, and will provide a forum for sharing best practice on the core aspects of running AAV gene therapy trials – including the background to these trials, differences between these and traditional clinical trials, and the key advice you need to establish a new trial site. The webcast will include presentations by experts from across Europe, as well as panel discussions and the opportunity for you to pose your questions to the experts in a live Q&A session.

Practical experiences from running gene therapy trials with Adeno-Associated Virus (AAV) vectors: The Primary Investigator's perspective

XX November 2020 | 18:00 GMT/19:00 CET

Speakers

Professor Francesco Muntoni

Professor of Paediatric Neurology, Director of the Dubowitz Neuromuscular Centre, at the UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Eugenio Mercuri

Professor of Paediatric Neurology at the Catholic University, Rome, Italy

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Laurent Servais

Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre, Invited Professor of Child Neurology at Liège University.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Nicolas Deconick

Chef de clinique neurologie pédiatrique Hôpital Universitaire Des Enfants Reine Fabiola (HUDERF), Brussel, Belgium

FULL BIO +

Professor Wolfgang Müller-Felber

Head of the centre of pediatric neuromuscular diseases at the v. Hauner children hospital, University of Munich, Munich, Bavaria, Germany

FULL BIO +

Speakers

Professor Francesco Muntoni

Professor of Paediatric Neurology, Director of the Dubowitz Neuromuscular Centre, at the UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Eugenio Mercuri

Professor of Paediatric Neurology at the Catholic University, Rome, Italy

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Laurent Servais

Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre, Oxford, UK; Invited Professor of Child Neurology at Liège University, Liège, Belgium.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Nicolas Deconick

Head of the paediatric neurology clinic at the Hôpital Universitaire Des Enfants Reine Fabiola (HUDERF), Brussels, Belgium

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor Wolfgang Müller-Felber

Head of the centre of pediatric neuromuscular diseases at the Dr von Hauner Children’s Hospital, University of Munich, Munich, Bavaria, Germany

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Agenda

25 minutes

Gene therapy trials – challenges and opportunities

  • Welcome, intro to the meeting and agenda, instructions for delegates

  • A brief history of gene therapy trials in Europe

  • Gene therapy trials vs traditional trials – what are the differences?

  • Reflections on successful gene therapy trials

  • Practical guidance on running multiple gene therapy trials at a single site

Speaker:
Prof Francesco Muntoni
Prof Eugenio Mercuri

15 minutes

Establishing a new trial site

  • Transferrable knowledge: how learnings from one site can be carried across to another
  • Priorities when establishing a new site

Speaker:
Prof Laurent Servais

20 minutes

Panel discussion

Personal experiences of trial management – what worked and what didn’t?

  • What similarities and differences are there between the approaches taken in the different countries?
  • ‘Top tips’ – what piece of advice would the faculty give to PIs initiating a new gene therapy trial?
  • Trial troubleshooting – what barriers/challenges are common and how could these be overcome?

Speaker:

Prof Francesco Muntoni / Prof Eugenio Mercuri (chairs)

Prof Laurent Servais / Prof Nicolas Deconick /
Prof Wolfgang Müller-Felber (faculty)

30 minutes

Live Q&A

Chairs:
Prof Francesco Muntoni
Prof Eugenio Mercuri

Book your place at the webinar

Practical experiences from running gene therapy trials with Adeno-Associated Virus (AAV) vectors: The Primary Investigator's perspective

XX November 2020 | 18:00 GMT/19:00 CET

Days
Hours
Min
Sec

Sponsorship statement:

Sponsorship statement: This is a non-promotional meeting funded and organised by Sarepta and Roche. These presentations and discussions are for educational purposes only and solely intended to provide scientific information on certain diseases. Nothing in these presentation and discussions should be construed as seeking to promote any of Sarepta or Roche’s therapies. Nothing in these presentations should be disclosed externally without the prior agreement of Sarepta and Roche.

Job code: XXX | Date of preparation: September 2020

© 2020 SAREPTA THERAPEUTICS AND F. HOFFMAN-LA ROCHE LTD. CONFIDENTIAL AND NOT FOR DISTRIBUTION.
COPYING OF THIS MATERIAL BY ANY MEANS WITHOUT THE PRIOR WRITTEN CONSENT OF SAREPTA AND ROCHE IS PROHIBITED

Terms and conditions | Privacy policy

© 2020 OmniaMed Communications Ltd.
All rights reserved
108 Cannon Street, London EC4N 6EU
Registered in the United Kingdom.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.